Abstract
Cognitive dysfunction disorders, such as Alzheimer’s disease and other forms of dementia, are prevalent among the geriatric population. The management of cognitive dysfunction disorders requires a multidisciplinary approach that includes pharmacological and non-pharmacological interventions. This article provides an overview of recent management approaches for geriatric populations suffering from cognitive dysfunction disorders. Pharmacological management includes the use of cholinesterase inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonists to improve cognitive function and delay disease progression. Non-pharmacological management includes cognitive stimulation therapy, physical activity, and social engagement to improve cognitive function and maintain quality of life. Occupational therapy and speech therapy can address functional impairments and communication difficulties associated with cognitive dysfunction disorders. Clinical trials to evaluate the effect and the safety of caregiver support can also play a significant role in laying down new strategies. Emerging therapies, such as immunotherapy, gene therapy, and stem cell therapy, hold promise for disease modification and prevention. However, these therapies are still in the early stages of development and require further research and. Overall, the management of cognitive dysfunction disorders in geriatric populations requires a personalized approach that considers the individual needs and preferences of each individual. Collaborative care models that involve patients, caregivers, and healthcare providers can promote effective disease management and improve patient outcomes. Future research should focus on identifying new therapeutic targets and interventions to prevent and treat cognitive dysfunction disorders in geriatric populations.

This publication has 21 references indexed in Scilit: